POSTER SESSION VI
Wednesday, March 2, 2011 — 1:00 PM - 4:00 PM
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
HEMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
194
microRNA Profiling in Blastoid Mantle Cell Lymphoma.
(1270)
WO Greaves, KP Patel, BA Barkoh, BM Mishra, S Li, Y Hui, LJ Medeiros, R Luthra - University of Texas MD Anderson Cancer Center, Houston
Quantitative Cyclin D1 Expression Is a Prognostic Indicator in Patients with Mantle Cell Lymphoma.
(1366)
A Siddon, R Torres, H Rinder, B Smith, J Howe, C Tormey - Yale University School of Medicine, New Haven, CT
CD5-Positive MALT Lymphoma: A Clinicopathologic Study of 9 Cases.
(1285)
J Jasso, L Chen, P Lin, S Li, RN Miranda, LJ Medeiros, CC Yin - UT MD Anderson Cancer Center, Houston, TX; UT Medical School, Houston, TX
Marginal Zone Lymphoma in Multiple Locations: A Progression or a De Novo Disease?
(1347)
A Rangel Filho, JR Chapman, OF Ikpatt - University of Miami, FL; Jackson Memorial Hospial, Miami, FL
Primary Follicular Lymphoma of the Small Intestine: A Morphologic, Immunohistochemical and Molecular Study of 7 Cases.
(1312)
C Martin, R Kitagawa, H Garcia Rivello, D Kohan, E Mocetti, M Narbaitz - Hematopathology Consultation, La Plata, Argentina; Hospital Italiano, Buenos Aires, Argentina; National Academy of Medicine & Fundaleu, Buenos Aires, Argentina
Thymic Extranodal Marginal Zone B Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Occurs in Patients without History of Autoimmune Disease, and Is Rarely Involved by MALT Lymphoma-Associated Genetic Alterations: Analysis of 6 Cases.
(1238)
HJ Cho, H Go, JH Paik, KC Jung, CW Kim, YK Jeon - Seoul National University Hospital College of Medicine, Republic of Korea
The Role of IGH and IGK Clonality Testing in Diagnostic Work-Up of Suspected Gastric Mucosa Associated Lymphoid Tissue (MALT) Lymphomas.
(1269)
B Graber, H Ratech, Q Pan, J Du, S Shen, Y Lo, C McMahon - Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
Can CD123 Immunohistochemical Stain for Plasmacytoid Dendritic Cells Be Used as an Adjunctive Diagnostic Marker in Marginal Zone Lymphomas at Different Sites?
(1220)
R Batra, V Ghali - St Luke's Roosevelt Hospital Center and Beth Medical Center, New York
Pediatric Follicular Lymphoma: A Comparison with Follicular Lymphoma in Young Adults.
(1308)
Q Liu, A Jegalian, M Raffeld, S Pittaluga, ES Jaffe - NCI/NIH, Bethesda, MD
Follicular Lymphoma "In Situ" and with Partial Lymph Node Involvement Represent Genetically Early Stages of Follicular Lymphoma Development.
(1210)
P Adam, I Salaverria, I Bonzheim, MA Piris, S Montes-Moreno, F Fend, R Siebert, L Quintanilla-Martinez - Eberhard-Karls-University, Tubingen, Germany; Christian-Albrechts-University, Kiel, Germany; Spanish National Cancer Center, Madrid, Spain
Prevalent Expression of IL-21 Receptor in Follicular Lyphoma and Potential Association with Poor-Outcome Disease.
(1367)
S Sikdar, B Wood, A Alhejaily, T Baetz, D LeBrun - Queen's University, Kingston, ON, Canada; Kingston General Hospital, ON, Canada
BCL6 Alternative Breakpoint Region (ABR) Rearrangement Is Associated with Lymphomas with Follicular Morphology.
(1419)
JM Ziai, L Ma, Y Natkunam, DA Arber - Stanford University Medical Center, CA
Gray Zone Lymphomas: Becoming More Black and White?
(1375)
TA Summers, FC Eberle, S Pittaluga, WH Wilson, K Dunleavy, M Raffeld, SM Hewitt, ES Jaffe - National Cancer Institute, NIH, Bethesda, MD
CD23 and TRAF1 Expression and Lack of BCL2/IGH Fusion Help Discriminate Primary Mediastinal Large B-Cell Lymphoma from Mediastinal Involvement by Systemic DLBCL.
(1246)
LN Dao, ME Law, GS Nowakowski, WR Macon - Mayo Clinic, Rochester, MN
Jun B Expression Is Associated with Non-GC (Germinal Center) B Cell Differentiation Immunophenotype, and Jun B and Jun D with High Proliferation of Tumor Cells in DLBCL.
(1337)
A Papoudou-Bai, A Batistatou, E Hatzimichael, A Dasoula, P Kanavaros, V Malamou-Mitsi - Medical School, University of Ioannina, Greece
Patched-1 (PTCH1) Hedgehog Pathway Protein Expression and Clinical Outcome in Diffuse Large B-Cell Lymphoma (DLBCL).
(1248)
MC Davies, L Li, C Sheehan, T Nazeer - Albany Medical College, NY
Differential Expression of RanGAP1 between Reactive and Neoplastic B-Cell Proliferations: Using Comparative Proteomics to Search Lymphoma Biomarker and Its Clinicopathologic Role.
(1230)
K-C Chang, H-L Song, C-H Huang, C Chang, Y-T Jin - National Cheng Kung University and Hospital, Tainan, Taiwan; Taiwan Adventist Hospital, Taipei, Taiwan
SYK Inhibition and Response Prediction in Diffuse Large B-Cell Lymphoma.
(1389)
LY Wang, S Cheng, HX Zhang, R Shaknovich, Z Song, P Lu, A Pandey, G Coffey, U Sinha - Weill Cornell Medical College, New York, NY; Portola Pharmaceuticals Inc., South San Francisco, CA
ITK and SYK Genes Involved Chromosome Translocation in Peripheral T-Cell Lymphomas.
(1404)
H Ye, W Zhang, B Li, G Dong, Y Zhou - Guilin Medical College, China; Hua Xi Hospital, Sichuan University, chengdu, China; Zhejiang University, Hangzhou, China; Tongren Hospital, Beijing, China
CD57+ Natural Killer Cells Are Associated with Better Overall Survival in DLBCL Patients.
(1301)
JH Lee, YJ Kwak, CH Kim, I Kim - Korea University Anam Hospital, Seoul, Korea; College of Medicine, Korea University, Seoul, Korea
Mature B-Cell Lymphomas with Blastoid Morphology: Clinicopathologic and Genetic Features of 33 Cases.
(1294)
R Kanagal Shamannna, LJ Medeiros, SA Wang, RN Miranda - UT MD Anderson Cancer Center, Houston
The Unique Immunophenotype of "Double-Hit Lymphomas".
(1274)
AM Harrington, H Olteanu, C Eshoa, SH Kroft - Medical College of Wisconsin, Milwaukee; Columbia St. Mary's Hospital, Milwaukee, WI
"Double Hit"High-Grade B-Cell Lymphomas: An Aggressive Disease with Heterogeneous Histologic Features and Clinical Outcome.
(1304)
S Li, LJ Medeiros, LE Fayad, PA Lennon, CC Yin, P Lin - The University of Texas MD Anderson Cancer Center, Houston
Bright CD38 and Dim CD20 by Flow Cytometry May Predict for Double Hit Lymphomas in MYC Rearranged High-Grade B-Cell Lymphomas.
(1397)
JS Willis, AC Seegmiller, N Uddin, NJ Karandikar, W Chen - UT Southwestern Medical Center, Dallas, TX
Expression of the c-MYC Protein Does Not Predict an 8q24 Translocation.
(1265)
JT Geyer, N Ippolito, S Barouk, A Orazi, S Ely - Weill Cornell Medical College, New York
Plasmablastic Lymphomas . Immunophenotypic Spectrum and MYC Translocation.
(1364)
T Shet, S Epari, S Dhende, M Sengar, R Nair - Tata Memorial Hospital, Mumbai, Maharashtra, India
button next to any title to add to Itinerary Planner...
Add
